• Login
    View Item 
    •   Home
    • 1 Published Research and Commentary
    • Trypanosomiasis/Sleeping Sickness
    • View Item
    •   Home
    • 1 Published Research and Commentary
    • Trypanosomiasis/Sleeping Sickness
    • View Item
    Jan 17, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CollectionTitleAuthorsSubjectsPublisherJournal

    Availability and affordability of treatment for Human African Trypanosomiasis.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Etchegorry Trop Med.pdf
    Size:
    46.97Kb
    Format:
    PDF
    Download
    Authors
    Etchegorry, M
    Helenport, J
    Pecoul, B
    Jannin, J
    Legros, D
    Affiliation
    Médecins Sans Frontières, 8 Rue Saint Sabin, Paris.
    Issue Date
    2001-11
    
    Metadata
    Show full item record
    Journal
    Tropical Medicine & International Health
    Abstract
    Human African Trypanosomiasis (HAT) is a re-emerging disease whose usual treatments are becoming less efficient because of the increasing parasite resistance. Availability of HAT drugs is poor and their production in danger because of technical, ecological and economic constraints. In view of this dramatic situation, a network involving experts from NGOs, WHO and pharmaceutical producers was commissioned with updating estimates of need for each HAT drug for the coming years; negotiations with potential producers of new drugs such as eflornithine; securing sustainable manufacturing of existing drugs; clinical research into new combinations of these drugs for first and second-line treatments; centralizing drug purchases and their distribution through a unique non-profit entity; and addressing regulatory and legal issues concerning new drugs.
    Publisher
    Wiley-Blackwell
    URI
    http://hdl.handle.net/10144/16877
    PubMed ID
    11703853
    Additional Links
    http://www.blackwell-synergy.com/loi/tmi
    Language
    en
    ISSN
    1360-2276
    Collections
    Trypanosomiasis/Sleeping Sickness

    entitlement

    Related articles

    • Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis.
    • Authors: Simarro PP, Franco J, Diarra A, Postigo JA, Jannin J
    • Issue date: 2012 Jun
    • [The return of sleeping sickness in an epidemic form: international action for drugs].
    • Authors: Kager PA
    • Issue date: 2002 Dec 28
    • Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
    • Authors: Robays J, Raguenaud ME, Josenando T, Boelaert M
    • Issue date: 2008 Feb
    • Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    • Authors: Nok AJ
    • Issue date: 2003 May
    • Production of sleeping-sickness treatment.
    • Authors: Pécoul B, Gastellu M
    • Issue date: 1999 Sep 11
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.